Goldman Sachs
VBIV

Goldman Sachs’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,189
Closed -$18.8K 4971
2024
Q1
$18.8K Buy
31,189
+825
+3% +$497 ﹤0.01% 4610
2023
Q4
$17.8K Buy
+30,364
New +$17.8K ﹤0.01% 4614
2023
Q2
Sell
-196,655
Closed -$59.6K 5200
2023
Q1
$59.6K Buy
196,655
+17,290
+10% +$5.24K ﹤0.01% 4742
2022
Q4
$70.1K Sell
179,365
-122,381
-41% -$47.9K ﹤0.01% 4741
2022
Q3
$213K Sell
301,746
-907,761
-75% -$641K ﹤0.01% 4687
2022
Q2
$978K Buy
1,209,507
+205,921
+21% +$167K ﹤0.01% 3957
2022
Q1
$1.67M Sell
1,003,586
-149,981
-13% -$249K ﹤0.01% 3710
2021
Q4
$2.7M Buy
1,153,567
+818,173
+244% +$1.91M ﹤0.01% 3276
2021
Q3
$1.04M Buy
335,394
+133,203
+66% +$414K ﹤0.01% 3940
2021
Q2
$677K Buy
202,191
+36,385
+22% +$122K ﹤0.01% 4258
2021
Q1
$516K Buy
165,806
+27,328
+20% +$85K ﹤0.01% 4331
2020
Q4
$381K Sell
138,478
-189,628
-58% -$522K ﹤0.01% 3972
2020
Q3
$938K Buy
328,106
+250,090
+321% +$715K ﹤0.01% 3353
2020
Q2
$242K Sell
78,016
-82,989
-52% -$257K ﹤0.01% 3914
2020
Q1
$152K Buy
161,005
+61,536
+62% +$58.1K ﹤0.01% 4030
2019
Q4
$137K Buy
+99,469
New +$137K ﹤0.01% 4081
2019
Q3
Sell
-549,644
Closed -$643K 4353
2019
Q2
$643K Buy
+549,644
New +$643K ﹤0.01% 3422
2018
Q4
Sell
-41,884
Closed -$101K 4280
2018
Q3
$101K Sell
41,884
-107,496
-72% -$259K ﹤0.01% 3952
2018
Q2
$411K Buy
+149,380
New +$411K ﹤0.01% 3605
2017
Q2
Sell
-69,696
Closed -$383K 4552
2017
Q1
$383K Buy
+69,696
New +$383K ﹤0.01% 3641
2016
Q2
Sell
-36,440
Closed -$86K 4661
2016
Q1
$86K Buy
36,440
+13,390
+58% +$31.6K ﹤0.01% 4074
2015
Q4
$56K Sell
23,050
-127
-0.5% -$309 ﹤0.01% 4154
2015
Q3
$61K Buy
+23,177
New +$61K ﹤0.01% 4295
2015
Q1
Sell
-24,186
Closed -$81K 4653
2014
Q4
$81K Buy
+24,186
New +$81K ﹤0.01% 4291